XTX Topco Ltd bought a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 55,376 shares of the company's stock, valued at approximately $401,000.
A number of other large investors have also recently added to or reduced their stakes in CORZ. FMR LLC raised its stake in Core Scientific by 2,937.7% during the fourth quarter. FMR LLC now owns 7,436,229 shares of the company's stock worth $104,479,000 after acquiring an additional 7,191,428 shares in the last quarter. Driehaus Capital Management LLC grew its holdings in Core Scientific by 112.1% in the 4th quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company's stock valued at $144,212,000 after buying an additional 5,424,901 shares in the last quarter. Fred Alger Management LLC acquired a new position in Core Scientific in the 4th quarter valued at $62,011,000. Beryl Capital Management LLC lifted its position in shares of Core Scientific by 24.3% during the 4th quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company's stock valued at $255,423,000 after acquiring an additional 3,548,396 shares during the period. Finally, Jericho Capital Asset Management L.P. bought a new stake in shares of Core Scientific during the 4th quarter valued at $39,240,000.
Insider Buying and Selling
In other news, insider Todd M. Duchene sold 7,759 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $12.39, for a total transaction of $96,134.01. Following the completion of the sale, the insider directly owned 2,049,689 shares of the company's stock, valued at $25,395,646.71. This trade represents a 0.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Yadin Rozov acquired 110,000 shares of Core Scientific stock in a transaction dated Wednesday, May 28th. The shares were bought at an average cost of $10.87 per share, with a total value of $1,195,700.00. Following the completion of the purchase, the director owned 475,687 shares in the company, valued at approximately $5,170,717.69. This represents a 30.08% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 117,759 shares of company stock worth $1,391,434 over the last quarter. Insiders own 1.40% of the company's stock.
Core Scientific Stock Performance
CORZ stock traded down $1.64 during midday trading on Wednesday, hitting $13.47. 11,791,554 shares of the stock were exchanged, compared to its average volume of 16,264,675. The stock's 50-day moving average price is $13.70 and its 200-day moving average price is $10.96. The stock has a market cap of $4.12 billion, a price-to-earnings ratio of -24.14 and a beta of 6.60. Core Scientific, Inc. has a fifty-two week low of $6.20 and a fifty-two week high of $18.63.
Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.03. The company had revenue of $78.63 million during the quarter, compared to analysts' expectations of $82.09 million. The firm's revenue for the quarter was down 44.3% compared to the same quarter last year. Research analysts anticipate that Core Scientific, Inc. will post 0.52 EPS for the current year.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on CORZ. Oppenheimer restated a "market perform" rating on shares of Core Scientific in a research report on Monday, July 7th. Craig Hallum cut Core Scientific from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 7th. Roth Mkm reaffirmed a "buy" rating and set a $20.00 target price on shares of Core Scientific in a research note on Thursday, June 26th. Roth Capital reaffirmed a "neutral" rating and set a $20.00 target price on shares of Core Scientific in a research note on Tuesday, July 8th. Finally, HC Wainwright reissued a "neutral" rating on shares of Core Scientific in a research note on Monday. One analyst has rated the stock with a sell rating, eleven have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $18.32.
Check Out Our Latest Research Report on Core Scientific
About Core Scientific
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Featured Articles
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access